Neuraxis (NRXS) director Watkins received 13,157 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Bradley Mitchell Watkins (director at Neuraxis Inc., NRXS) reported that they received 13,157 shares on Jan 17, 2025. After these transactions the filing shows 24,737 shares held directly.
- Reporting person
- Watkins Bradley Mitchell
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | Grant or award (A) | Common Stock1 | +13,157 | $2.85 | $37.5K | 24,737 direct |
Holdings before and after
- Common Stock: 11,580 to 24,737 direct
Footnotes from the filing
- 1. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Watkins report in this NRXS Form 4?
Bradley Mitchell Watkins (director at Neuraxis Inc., NRXS) reported that they received 13,157 shares on Jan 17, 2025. After these transactions the filing shows 24,737 shares held directly.
How many NRXS shares does Watkins hold after this filing?
The filing shows 24,737 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for NRXS
Earlier insider filings at NRXS
- Sep 10, 2025Director Keyser Jane Elizabeth was granted 13,157 shares, increasing direct ownership by 114% to 24,737 units (SEC Form 4)
- Sep 10, 2025SEC Form 4 filed by CMO, SVP Science & Tech Miranda Adrian
- Sep 10, 2025SEC Form 4 filed by CRO, CCO, CPO Carrico Thomas Joeseph
- Jul 3, 2025Large owner Masimo Corp sold $1,847,986 worth of shares (821,327 units at $2.25) and converted options into 289,779 shares, closing all direct ownership in the company (SEC Form 4)
- Jul 3, 2025Large owner Hannasch Brian bought $800,001 worth of shares (355,556 units at $2.25), increasing direct ownership by 46% to 1,131,522 units (SEC Form 4)
Quantisnow market dataAMEX
NRXS
Neuraxis Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2023
Get push alerts for NRXS
Full NRXS profile on Quantisnow Follow NRXS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time